ArticleDrugs in R&D2017

A Phase I Study of Combination Therapy with Sorafenib and 5-Fluorouracil in Patients with Advanced Hepatocellular Carcinoma.

Takuya Sho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.